Kit Check co-founders Tim Kress-Spatz and Kevin MacDonald in their office in Washington D.C. last year
Kevin MacDonald, co-founder and CEO, Kit Check
Earlier this week, Kit Check announced our Series B funding of $12 million led by Kaiser Permanente Ventures. We successfully raised our Series A of $10.4 million in July 2013 after joining Rock Health’s portfolio. In the eighteen months between funding rounds we grew from seven to 144 hospital customers with over 5,000 users on our cloud-based system and 3.6 million medications tracked.
Kit Check represents the only successful Internet of Things success story for hospital consumables to date. We believe it is also the best example of successful cloud software adoption in hospital operations. We are helping hospitals reduce cost and increase patient safety related to medication dispensing and use, which is an important industry contribution. It’s a great story and far from over. One constant throughout has been strong support from Rock Health.